Shire $5.2 billion acquisition of NPS Pharmaceuticals

Overview:

• Dublin-based pharmaceutical company Shire has completed its $5.2 billion acquisition of NPS Pharmaceuticals.
• The deal came in the wake of a failed bid by Shire to sell itself to AbbVie. 
• Shire paid $46 per NPS share. 
• Citigroup Global Markets and Lazard acted as financial advisers for Shire, while Goldman Sachs and Leerink Partners acted for NPS. 
• The deal was first announced in January 2015. 

Kurt Stumpo - Journalist